scispace - formally typeset
M

Meleri Jones

Researcher at Queen Mary University of London

Publications -  35
Citations -  1898

Meleri Jones is an academic researcher from Queen Mary University of London. The author has contributed to research in topics: Virus & Hepatitis C virus. The author has an hindex of 14, co-authored 33 publications receiving 1345 citations. Previous affiliations of Meleri Jones include University College London.

Papers
More filters
Journal ArticleDOI

Temporal analysis of early immune responses in patients with acute hepatitis B virus infection.

TL;DR: The early stages of acute HBV are characterized by induction of interleukin-10 rather than type I IFN, accompanied by a temporary attenuation of NK and T-cell responses, which are correlated with temporal changes in viral load, serology, and liver inflammation.
Journal ArticleDOI

Dengue Virus Inhibits Alpha Interferon Signaling by Reducing STAT2 Expression

TL;DR: It is shown that in replicon-containing cells dengue virus RNA replication and the replication of encephalomyocarditis virus, an IFN-sensitive virus, are resistant to the antiviral effects ofIFN-α.
Journal ArticleDOI

Dengue Virus NS5 Inhibits Interferon-α Signaling by Blocking Signal Transducer and Activator of Transcription 2 Phosphorylation

TL;DR: DENV NS5 is a potent and specific type I IFN antagonist, which binds signal transducer and activator of transcription 2 and inhibits its phosphorylation.
Journal ArticleDOI

Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure

Catherine J. Reynolds, +125 more
- 14 Jun 2022 - 
TL;DR: B and T cell immunity against previous variants of concern was enhanced in triple vaccinated individuals, but magnitude of T and B cell responses against B.1.1 .1.529 spike protein was reduced.